Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)

Peer Review reports

Original Submission
24 Apr 2020	Submitted	Original manuscript
27 Apr 2020	Author responded	Author comments - Qingsong Ye
4 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
27 Apr 2020	Submitted	Manuscript version 2
Publishing
5 May 2020	Editorially accepted
12 Jun 2020	Article published	10.1186/s13063-020-04380-5

Back to article page